Transforming growth factor β1 increases the expressions of high molecular weight tropomyosin isoforms and vinculin and suppresses the transformed phenotypes in human lung carcinoma cells

This publication has 17 references indexed in Scilit:

• Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells
  Cancer, 1995
• Actin, its associated proteins and metastasis
  Cell Motility, 1995
• Antisense oligodeoxyribonucleotide inhibition of TGF-β1 gene expression and alterations in the growth and malignant properties of mouse fibrosarcoma cells
  Gene, 1994
• Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor β1
  British Journal of Cancer, 1994
• A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells.
  Molecular and Cellular Biology, 1994
• Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene.
  Proceedings of the National Academy of Sciences, 1991
• Transforming growth factor-β suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloprotease
  Biochemical and Biophysical Research Communications, 1991
• Differential expression of a tropomyosin isoform in low- and high-metastatic Lewis lung carcinoma cells.
  Molecular and Cellular Biology, 1988
• Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes.
  Molecular and Cellular Biology, 1985
• Type beta transforming growth factor: a bifunctional regulator of cellular growth.
  Proceedings of the National Academy of Sciences, 1985